House Subcommittee Chair Seeks Delay Of FDA Foundation Launch (Medical News Today)
House Appropriations Subcommittee on Agriculture Chair Rosa DeLauro (D-Conn.) on Thursday in a letter asked FDA officials to delay the launch of the Reagan-Udall Foundation because of concerns about the relationship between the foundation and industries regulated by the agency, CongressDaily reports (Edney, CongressDaily, 11/5). [click link for full article]

FDA damned if it does, damned if it doesn't (CNN Money)
The FDA just can't win. After years of public ridicule and congressional scrutiny, the Food and Drug Administration is taking a tougher stance against drugmakers in its review of new medicines. That new cautiousness, however, rankles its most powerful constituents: Big Pharma CEOs who charge that the agency is standing in the way of new medicines - and progress.

VIVUS Reports Third Quarter 2007 Financial Results and Highlights (Business Wire via Yahoo! Finance)
MOUNTAIN VIEW, Calif.----VIVUS, Inc. , a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced its financial results and highlights for the third quarter of 2007.